Shuttle Pharmaceuticals (NASDAQ: SHPH) reported a quarterly loss of $(3.10) per share for the second quarter, marking a 90.58% improvement compared to the same period last year.

This significant reduction in losses highlights a substantial narrowing of the deficit year-over-year. The company previously reported a loss of $(32.90) per share in the corresponding quarter of the prior fiscal year.

Financial Performance Snapshot

The table below details the change in earnings per share (EPS) for the reported quarter.

What the Numbers Show

The data indicates a dramatic contraction in the magnitude of the loss per share. While the company remains in a loss-making position, the gap between the current and prior year figures suggests a significant operational or financial shift that reduced the per-share deficit by over 90%. No revenue or EBITDA figures were disclosed in the source to contextualize this EPS movement against top-line performance.

United Dogecoin is evaluating proprietary data center and power generation opportunities in North America to build a long-term digital infrastructure platform supporting Dogecoin mining and future artificial intelligence workloads. The company, owned by Shuttle Pharmaceutical Holdings Inc, is assessing behind-the-meter power generation assets in Idaho and Alberta as part of a strategy aimed at lowering operating costs and increasing flexibility for its growing mining business. This initiative is part of a broader strategy to create new revenue opportunities and drive long-term shareholder value.

United Dogecoin views Idaho and Alberta as attractive locations due to competitive electricity markets, favorable climate conditions, and expanding energy infrastructure. The company also cited access to low-cost natural gas, renewable energy assets, and regulatory environments supportive of industrial power development as factors driving its evaluation. Ryan Trasolini, Co-CEO of Shuttle and a founder of United Dogecoin, stated that ownership of power and data center infrastructure has the potential to improve operating economics, increase strategic flexibility, and create future opportunities in AI and high-performance computing.

Rising demand for AI and high-performance computing infrastructure could create revenue opportunities beyond cryptocurrency mining. Proprietary facilities may eventually support third-party computing customers and emerging AI workloads, potentially diversifying future revenue streams. The company continues to move forward with the deployment of its initial ElphaPex miners and is working to energize the mining units as they arrive at its hosted data center facility. This deployment represents the first step toward establishing a scalable Dogecoin mining operation powered by low-cost North American energy.

In May, Shuttle Pharmaceutical merged with United Dogecoin to become the largest public Dogecoin miner. United Dogecoin expects to provide additional updates on miner deployment, power initiatives, and data center development as those projects advance.